Cell Reports (Mar 2023)

Tumor suppressor p53 regulates heat shock factor 1 protein degradation in Huntington’s disease

  • Rachel H. Mansky,
  • Erin A. Greguske,
  • Dahyun Yu,
  • Nicole Zarate,
  • Taylor A. Intihar,
  • Wei Tsai,
  • Taylor G. Brown,
  • Mackenzie N. Thayer,
  • Kompal Kumar,
  • Rocio Gomez-Pastor

Journal volume & issue
Vol. 42, no. 3
p. 112198

Abstract

Read online

Summary: p53 and HSF1 are two major transcription factors involved in cell proliferation and apoptosis, whose dysregulation contributes to cancer and neurodegeneration. Contrary to most cancers, p53 is increased in Huntington’s disease (HD) and other neurodegenerative diseases, while HSF1 is decreased. p53 and HSF1 reciprocal regulation has been shown in different contexts, but their connection in neurodegeneration remains understudied. Using cellular and animal models of HD, we show that mutant HTT stabilized p53 by abrogating the interaction between p53 and E3 ligase MDM2. Stabilized p53 promotes protein kinase CK2 alpha prime and E3 ligase FBXW7 transcription, both of which are responsible for HSF1 degradation. Consequently, p53 deletion in striatal neurons of zQ175 HD mice restores HSF1 abundance and decrease HTT aggregation and striatal pathology. Our work shows the mechanism connecting p53 stabilization with HSF1 degradation and pathophysiology in HD and sheds light on the broader molecular differences and commonalities between cancer and neurodegeneration.

Keywords